Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

5,425.00p
   
  • Change Today:
      15.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 3,920.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 112,706
  • Market Cap: £3,567.88m
  • RiskGrade: 128
  • Beta: 0.01

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
30-Jun-17 Interim 00.00      
  Final 13.30p 25-Nov-11 09-Nov-11 11-Nov-11
30-Jun-18 Interim 8.10p 04-Apr-18 08-Mar-18 09-Mar-18
  Final 17.90p 30-Nov-18 15-Nov-18 16-Nov-18
30-Jun-19 Interim 8.90p 04-Apr-19 07-Mar-19 08-Mar-19
  Final 18.80p 29-Nov-19 07-Nov-19 08-Nov-19
30-Jun-20 Interim 9.40p 02-Apr-20 05-Mar-20 06-Mar-20
  Final 19.70p 11-Dec-20 19-Nov-20 20-Nov-20
30-Jun-21 Interim 10.30p 01-Apr-21 04-Mar-21 05-Mar-21
  Final 21.70p 10-Dec-21 18-Nov-21 19-Nov-21

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 5,425.00p
Change Today 15.00p
% Change 0.28 %
52 Week High 6,070.00
52 Week Low 3,920.00
Volume 112,706
Shares Issued 65.77m
Market Cap £3,567.88m
Beta 0.01
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.59% below the market average97.59% below the market average97.59% below the market average97.59% below the market average97.59% below the market average
96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average
Price Trend
57.58% above the market average57.58% above the market average57.58% above the market average57.58% above the market average57.58% above the market average
52.38% above the sector average52.38% above the sector average52.38% above the sector average52.38% above the sector average52.38% above the sector average
Income
64.5% below the market average64.5% below the market average64.5% below the market average64.5% below the market average64.5% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Growth
83.43% above the market average83.43% above the market average83.43% above the market average83.43% above the market average83.43% above the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 3
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 18-Nov-21 04-Mar-21
Paid 10-Dec-21 01-Apr-21
Amount 21.70p 10.30p

Trades for 15-Oct-2021

Time Volume / Share Price
16:35 79,759 @ 5,425.00p
16:29 1,000 @ 5,450.00p
16:29 16 @ 5,445.00p
16:29 4 @ 5,445.00p
16:29 136 @ 5,445.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page